In the United States alone, an estimated 20 million people have age-related macular degeneration (AMD), and almost 1.5 million have advanced AMD with significant central vision loss. February is AMD awareness month, and our award-winning ophthalmologist, Ernest W. Kornmehl, MD, FACS, highlights the first and only medication approved to treat late-stage dry AMD (geographic atrophy), Syfovre™…. Read the full article
